MMP2 and adenocarcinoma: In our study, we also observed greater levels of MMP-2 in patients with other lung neoplasms than in patients with adenocarcinoma or squamous cell carcinoma that could be attributed to a higher prevalence of distant metastases in this group of patients, which included individuals with metastases to the lungs from other neoplasms.